Banerjee, D.
Winocour, P.
Chowdhury, T. A.
De, P.
Wahba, M.
Montero, R.
Fogarty, D.
Frankel, A. H.
Karalliedde, J.
Mark, P. B.
Patel, D. C.
Pokrajac, A.
Sharif, A.
Zac-Varghese, S.
Bain, S.
Dasgupta, I. https://orcid.org/0000-0002-7448-2677
,
Article History
Received: 14 April 2021
Accepted: 28 October 2021
First Online: 3 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: AF has attended drug advisory boards of Boehringer Ingleheim, Astra Zeneca, NAPP, Novo Nordisk, MSD, VP UK.PBM has received honoraria from Pfizer, AstraZeneca, Novartis, Bristol Myers Squibb, Napp, Vifor and Pharmacosmos and research support from Boehringer Ingelheim. PBM is also an Associate Editor for BMC Nephrology.PW has received honoraria for delivering educational meetings and/or attending advisory boards for Abbott, Astra Zeneca, Bayer, BI, Eli Lilly, MSD, Napp, Sanofi, Novo and Vifor Pharmaceuticals.SCB reported receiving personal fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk and Sanofi-Aventis (honoraria); Medscape (funding for the development of educational programmes); All-Wales Medicines Strategy Group and National Institute for Health and Care Excellence UK (providing expert advice) and is a shareholder of Glycosmedia.PD has received honoraria for educational meetings from Astra Zeneca, Janssen, Boehringer Ingelheim, Novo, Sanofi, Novartis, Abbott, MSD, Takeda, Roche, Lilly, Ascensia, BD, Internis, GSK, Menarini, Bayer and Besins.DB has received grant from AsraZeneca and speaker fees from Vifor Pharma.JK has received honoraria for edelivering educational meetings and/ or attending advisory boards from Boehringer Ingelheim, AstraZeneca, Sanofi, Napp; and research grants from AstraZeneca and Sanofi.ID is chief investigator in the UK for three GSK sponsored trials and has chaired GSK advisory board. He has received a research grant from Sanofi Genzyme. He is also the Honorary Secretary of the Renal Association, UK.Other authors have declared no competing interests.